Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TRIB
日付受信時刻ニュースソース見出しコード企業名
2024/06/2420 : 00GlobeNewswire Inc.Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM SensorNASDAQ:TRIBTrinity Biotech PLC
2024/06/1022 : 10GlobeNewswire Inc.Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes AssociationNASDAQ:TRIBTrinity Biotech PLC
2024/06/0317 : 00GlobeNewswire Inc.Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated TechnologyNASDAQ:TRIBTrinity Biotech PLC
2024/05/2820 : 55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/05/2321 : 00GlobeNewswire Inc.Trinity Biotech Announces Q1 2024 Financial Results and Reiterates GuidanceNASDAQ:TRIBTrinity Biotech PLC
2024/05/1702 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/05/1622 : 18GlobeNewswire Inc.Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAINASDAQ:TRIBTrinity Biotech PLC
2024/05/1400 : 42GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesNASDAQ:TRIBTrinity Biotech PLC
2024/05/0823 : 36GlobeNewswire Inc.Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentNASDAQ:TRIBTrinity Biotech PLC
2024/05/0813 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
2024/05/0805 : 25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
2024/04/0420 : 30GlobeNewswire Inc.Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesNASDAQ:TRIBTrinity Biotech PLC
2024/03/2907 : 39GlobeNewswire Inc.Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
2024/03/0900 : 03GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:TRIBTrinity Biotech PLC
2024/02/1604 : 11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
2024/02/1602 : 34GlobeNewswire Inc.Trinity Biotech Plc Finalizes Effective Date of ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
2024/02/1323 : 00GlobeNewswire Inc.Trinity Biotech Plc Announces Plan to Implement ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
2024/02/1009 : 51Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TRIBTrinity Biotech PLC
2024/02/0822 : 30GlobeNewswire Inc.Trinity Biotech to Present at Emerging Growth ConferenceNASDAQ:TRIBTrinity Biotech PLC
2024/02/0722 : 30GlobeNewswire Inc.Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA CodeNASDAQ:TRIBTrinity Biotech PLC
2024/02/0201 : 37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/02/0201 : 33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2024/01/3121 : 05GlobeNewswire Inc.Trinity Biotech Announces Q3 2023 Financial Results & Business UpdateNASDAQ:TRIBTrinity Biotech PLC
2024/01/3121 : 02GlobeNewswire Inc.Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and IndiaNASDAQ:TRIBTrinity Biotech PLC
2024/01/3121 : 00GlobeNewswire Inc.Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.NASDAQ:TRIBTrinity Biotech PLC
2024/01/3107 : 23GlobeNewswire Inc.Trinity Biotech plc to Host Investor CallNASDAQ:TRIBTrinity Biotech PLC
2024/01/0306 : 17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
2024/01/0306 : 13Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
2024/01/0304 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
2023/12/2722 : 57GlobeNewswire Inc.Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to KenyaNASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

最近閲覧した銘柄

Delayed Upgrade Clock